Overview

Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition

Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics and bioequivalence of isotretinoin formulations after administration of single doses to normal, non-smoking,healthy males under fasting conditions
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Isotretinoin